Literature DB >> 23011222

Bringing the genomic landscape of small-cell lung cancer into focus.

M Catherine Pietanza, Marc Ladanyi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011222     DOI: 10.1038/ng.2415

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  15 in total

Review 1.  Neuroendocrine tumors of the lung: an update.

Authors:  Natasha Rekhtman
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

2.  Genetically informed lung cancer medicine.

Authors:  William Pao; A John Iafrate; Zengliu Su
Journal:  J Pathol       Date:  2010-10-25       Impact factor: 7.996

3.  Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Authors:  Jonathan Weiss; Martin L Sos; Danila Seidel; Martin Peifer; Thomas Zander; Johannes M Heuckmann; Roland T Ullrich; Roopika Menon; Sebastian Maier; Alex Soltermann; Holger Moch; Patrick Wagener; Florian Fischer; Stefanie Heynck; Mirjam Koker; Jakob Schöttle; Frauke Leenders; Franziska Gabler; Ines Dabow; Silvia Querings; Lukas C Heukamp; Hyatt Balke-Want; Sascha Ansén; Daniel Rauh; Ingelore Baessmann; Janine Altmüller; Zoe Wainer; Matthew Conron; Gavin Wright; Prudence Russell; Ben Solomon; Elisabeth Brambilla; Christian Brambilla; Philippe Lorimier; Steinar Sollberg; Odd Terje Brustugun; Walburga Engel-Riedel; Corinna Ludwig; Iver Petersen; Jörg Sänger; Joachim Clement; Harry Groen; Wim Timens; Hannie Sietsma; Erik Thunnissen; Egbert Smit; Daniëlle Heideman; Federico Cappuzzo; Claudia Ligorio; Stefania Damiani; Michael Hallek; Rameen Beroukhim; William Pao; Bert Klebl; Matthias Baumann; Reinhard Buettner; Karen Ernestus; Erich Stoelben; Jürgen Wolf; Peter Nürnberg; Sven Perner; Roman K Thomas
Journal:  Sci Transl Med       Date:  2010-12-15       Impact factor: 17.956

4.  Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress.

Authors:  J P Chute; T Chen; E Feigal; R Simon; B E Johnson
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.

Authors:  Natasha Rekhtman; Paul K Paik; Maria E Arcila; Laura J Tafe; Geoffrey R Oxnard; Andre L Moreira; William D Travis; Maureen F Zakowski; Mark G Kris; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

7.  The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.

Authors:  Olivier E Pardo; John Latigo; Rosemary E Jeffery; Emma Nye; Richard Poulsom; Bradley Spencer-Dene; Nick R Lemoine; Gordon W Stamp; Eric O Aboagye; Michael J Seckl
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

8.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Authors:  Martin Peifer; Lynnette Fernández-Cuesta; Martin L Sos; Julie George; Danila Seidel; Lawryn H Kasper; Dennis Plenker; Frauke Leenders; Ruping Sun; Thomas Zander; Roopika Menon; Mirjam Koker; Ilona Dahmen; Christian Müller; Vincenzo Di Cerbo; Hans-Ulrich Schildhaus; Janine Altmüller; Ingelore Baessmann; Christian Becker; Bram de Wilde; Jo Vandesompele; Diana Böhm; Sascha Ansén; Franziska Gabler; Ines Wilkening; Stefanie Heynck; Johannes M Heuckmann; Xin Lu; Scott L Carter; Kristian Cibulskis; Shantanu Banerji; Gad Getz; Kwon-Sik Park; Daniel Rauh; Christian Grütter; Matthias Fischer; Laura Pasqualucci; Gavin Wright; Zoe Wainer; Prudence Russell; Iver Petersen; Yuan Chen; Erich Stoelben; Corinna Ludwig; Philipp Schnabel; Hans Hoffmann; Thomas Muley; Michael Brockmann; Walburga Engel-Riedel; Lucia A Muscarella; Vito M Fazio; Harry Groen; Wim Timens; Hannie Sietsma; Erik Thunnissen; Egbert Smit; Daniëlle A M Heideman; Peter J F Snijders; Federico Cappuzzo; Claudia Ligorio; Stefania Damiani; John Field; Steinar Solberg; Odd Terje Brustugun; Marius Lund-Iversen; Jörg Sänger; Joachim H Clement; Alex Soltermann; Holger Moch; Walter Weder; Benjamin Solomon; Jean-Charles Soria; Pierre Validire; Benjamin Besse; Elisabeth Brambilla; Christian Brambilla; Sylvie Lantuejoul; Philippe Lorimier; Peter M Schneider; Michael Hallek; William Pao; Matthew Meyerson; Julien Sage; Jay Shendure; Robert Schneider; Reinhard Büttner; Jürgen Wolf; Peter Nürnberg; Sven Perner; Lukas C Heukamp; Paul K Brindle; Stefan Haas; Roman K Thomas
Journal:  Nat Genet       Date:  2012-09-02       Impact factor: 38.330

9.  Sox2 is required for maintenance and differentiation of bronchiolar Clara, ciliated, and goblet cells.

Authors:  David H Tompkins; Valérie Besnard; Alexander W Lange; Susan E Wert; Angela R Keiser; April N Smith; Richard Lang; Jeffrey A Whitsett
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  A small-cell lung cancer genome with complex signatures of tobacco exposure.

Authors:  Erin D Pleasance; Philip J Stephens; Sarah O'Meara; David J McBride; Alison Meynert; David Jones; Meng-Lay Lin; David Beare; King Wai Lau; Chris Greenman; Ignacio Varela; Serena Nik-Zainal; Helen R Davies; Gonzalo R Ordoñez; Laura J Mudie; Calli Latimer; Sarah Edkins; Lucy Stebbings; Lina Chen; Mingming Jia; Catherine Leroy; John Marshall; Andrew Menzies; Adam Butler; Jon W Teague; Jonathon Mangion; Yongming A Sun; Stephen F McLaughlin; Heather E Peckham; Eric F Tsung; Gina L Costa; Clarence C Lee; John D Minna; Adi Gazdar; Ewan Birney; Michael D Rhodes; Kevin J McKernan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

View more
  24 in total

1.  Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia.

Authors:  Darren R Brenner; Christopher I Amos; Yonathan Brhane; Maria N Timofeeva; Neil Caporaso; Yufei Wang; David C Christiani; Heike Bickeböller; Ping Yang; Demetrius Albanes; Victoria L Stevens; Susan Gapstur; James McKay; Paolo Boffetta; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Frank Skorpen; Maiken E Gabrielsen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Peter Broderick; Timothy Eisen; Xifeng Wu; Di Zhang; Wei Chen; Margaret R Spitz; Yongyue Wei; Li Su; Dong Xie; Jun She; Keitaro Matsuo; Fumihiko Matsuda; Hidemi Ito; Angela Risch; Joachim Heinrich; Albert Rosenberger; Thomas Muley; Hendrik Dienemann; John K Field; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Michael P A Davies; Michael Marcus; John McLaughlin; Irene Orlow; Younghun Han; Yafang Li; Xuchen Zong; Mattias Johansson; Geoffrey Liu; Shelley S Tworoger; Loic Le Marchand; Brian E Henderson; Lynne R Wilkens; Juncheng Dai; Hongbing Shen; Richard S Houlston; Maria T Landi; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2015-09-10       Impact factor: 4.944

Review 2.  Targeted drugs in small-cell lung cancer.

Authors:  Mariacarmela Santarpia; Maria Grazia Daffinà; Niki Karachaliou; Maria González-Cao; Chiara Lazzari; Giuseppe Altavilla; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

3.  Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.

Authors:  Masahiro Morise; Tomoyuki Hishida; Akiko Takahashi; Junji Yoshida; Yuichiro Ohe; Kanji Nagai; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-12       Impact factor: 4.553

4.  Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.

Authors:  Natasha Rekhtman; Maria C Pietanza; Matthew D Hellmann; Jarushka Naidoo; Arshi Arora; Helen Won; Darragh F Halpenny; Hangjun Wang; Shaozhou K Tian; Anya M Litvak; Paul K Paik; Alexander E Drilon; Nicholas Socci; John T Poirier; Ronglai Shen; Michael F Berger; Andre L Moreira; William D Travis; Charles M Rudin; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2016-03-09       Impact factor: 12.531

Review 5.  Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells.

Authors:  Gerhard Hamilton; Barbara Rath; Otto Burghuber
Journal:  Transl Lung Cancer Res       Date:  2015-06

Review 6.  Circulating tumor cell interactions with macrophages: implications for biology and treatment.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Transl Lung Cancer Res       Date:  2017-08

Review 7.  Smoking, inflammation and small cell lung cancer: recent developments.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Wien Med Wochenschr       Date:  2015-08-20

8.  Lung Cancer: One Disease or Many.

Authors:  Timothy D O'Brien; Peilin Jia; Melinda C Aldrich; Zhongming Zhao
Journal:  Hum Hered       Date:  2018-06-05       Impact factor: 0.444

9.  How to target small cell lung cancer.

Authors:  Gerhard Hamilton; Barbara Rath; Ernst Ulsperger
Journal:  Oncoscience       Date:  2015-08-21

10.  Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer.

Authors:  Gerhard Hamilton; Barbara Rath; Lukas Klameth; Maximilian Hochmair
Journal:  Oncoscience       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.